merck vaccine - Search News

Merck, Gardasil

Merck prevails in US safety litigation over Gardasil HPV vaccine

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of the drugmaker's best-selling products.

Bloomberg on MSN · 16h

Federal Judge Rules in Merck’s Favor in Gardasil Safety Suit

A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.

Markets Insider · 16h

Judge rules in Merck’s favor over Gardasil complaints, Bloomberg says

U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma

Reuters on MSN · 15h

Merck prevails in Gardasil safety litigation

A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision made public on Tuesday by U.

Merck, North Carolina

Reuters on MSN · 1d

Merck opens vaccine manufacturing facility in North Carolina

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Dru

The News & Observer on MSN · 17h

Merck opens $1 billion addition in north Durham to boost production of popular vaccine

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

NJBIZ · 13h

Merck opens $1B vaccine production facility (updated)

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion toward U.S. capital investments it's made since 2018.

Sharyl Attkisson: An interview with MMR vaccine whistleblower Stephen Krahling

Scientist Stephen Krahling worked on a project at Merck called “Protocol 7” and was uniquely positioned to blow the whistle on what he learned.

Just The News4d

Merck virologist recalls becoming whistleblower over maker's blockbuster MMR measles, mumps vaccine

Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

6don MSN

Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

1don MSN

Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds

We recently compiled a list of the 10 Most Undervalued US Stocks to Buy According to Hedge Funds. In this article, we are ...

CDC plans study into potential vaccines, autism connections, Reuters reports

The U.S. CDC plans to embark on a large study into potential connections between vaccines and autism, despite extensive scientific research ...

15hon MSN

Merck scores victory in Gardasil lawsuits as judge questions evidence

A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results